(Q30248486)

13 June 2017

1 reference

title

Vaccine-preventable disease and the under-utilization of immunizations in complex humanitarian emergencies (English)

1 reference

13 June 2017

0 references

Ryan M Close

1

1 reference

13 June 2017

Catherine Pearson

series ordinal

2

1 reference

13 June 2017

Jennifer Cohn

series ordinal

3

1 reference

13 June 2017

language of work or name

English

0 references

publication date

12 August 2016

1 reference

13 June 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

13 June 2017

volume

34

1 reference

13 June 2017

issue

39

1 reference

13 June 2017

page(s)

4649-4655

1 reference

Complex humanitarian emergencies: a major global health challenge.

13 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Emergencies in developed countries: are aid organisations ready to adapt?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

The public health aspects of complex emergencies and refugee situations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Measles vaccination in humanitarian emergencies: a review of recent practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Estimates of measles case fatality ratios: a comprehensive review of community-based studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Where and why are 10 million children dying every year?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

The burden of acute respiratory infections in crisis-affected populations: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Infectious diseases following natural disasters: prevention and control measures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Child health in complex emergencies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Mortality rates, causes of death, and health status among displaced and resident populations of Kabul, Afghanistan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

The devastation of Bam: an overview of health issues 1 month after the earthquake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Post-flood--infectious diseases in Mozambique

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

inferred from DOI database lookup

7 January 2021

based on heuristic

Earthquakes in El Salvador: a descriptive study of health concerns in a rural community and the clinical implications – part II

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Infectious diseases in a Nicaraguan refugee camp in Costa Rica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Waterborne diseases pose threat in Pakistan as floods strike

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Infectious diseases threaten refugees entering Pakistan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Progress towards demonstrating the impact of Haemophilus influenzae type b conjugate vaccines globally

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Rotavirus diarrhea among children less than 5 years of age in Urban Ghana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Gastroenteritis attributable to rotavirus in hospitalized Saudi Arabian children in the period 2007-2008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Rotavirus associated gastroenteritis in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Burden of rotavirus gastroenteritis in the pediatric population in Central and Eastern Europe: serotype distribution and burden of illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Incidence of Haemophilus influenzae type b disease in The Gambia 14 years after introduction of routine Haemophilus influenzae type b conjugate vaccine immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Impact of Haemophilus influenzae Type b conjugate vaccine in Mongolia: prospective population-based surveillance, 2002-2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Decline in severe diarrhea hospitalizations after the introduction of rotavirus vaccination in Ghana: A prevalence study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Reduction in Rotavirus Disease and Sustained Predominance of G2P[4] Rotavirus Strain following Introduction of Rotavirus Vaccine in Recife, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Vaccines for preventing rotavirus diarrhoea: vaccines in use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Human rotavirus vaccine (Rotarix): focus on effectiveness and impact 6 years after first introduction in Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Effect of rotavirus vaccine on childhood diarrhea mortality in five Latin American countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Comparative immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

The immunogenicity of Hemophilus influenzae type B polysaccharide-Neisseria meningitidis group B outer membrane protein complex vaccine in infants and young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Estimation of the indirect effect of Haemophilus influenzae type b conjugate vaccine in an American Indian population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Protection against gastroenteritis in US households with children who received rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Communicable diseases in complex emergencies: impact and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

The impoverished gut--a triple burden of diarrhoea, stunting and chronic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Prolonged episodes of acute diarrhea reduce growth and increase risk of persistent diarrhea in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

The effect of a vaccination program on child anthropometry: evidence from India's Universal Immunization Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Antimicrobial resistance in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Increase of β-lactam-resistant invasive Haemophilus influenzae in Sweden, 1997 to 2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.025

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2016.08.025

1 reference

13 June 2017

1 reference